COA/RT-2026-145Verified
Save as PDFCertificate of Analysis
PuriLab Analytical
Retatrutide 10 mg
RT-2026-145Lot 11112026Analyzed November 20, 2026

Timeline
Ordered
November 11, 2026
Received
November 19, 2026
Analyzed
November 20, 2026
Sample
Name
Retatrutide 10 mg
Expected
Retatrutide
Amount
1 vial, lyophilized powder
Testing
Client
Lost Longevity
Test type
Content & purity
Method
HPLC-UV
Content, how much is in it
10.99mg
Label claim: 10 mg
Purity, how clean it is
99.8%
Measured, not estimated. Purity is calculated from the full chromatogram shown above.
Chromatogram
HPLC-UV
13.44 min, Retatrutide, 99.8%
Analyst Comments
White lyophilized powder, blue-cap vial, received sealed.
Analyst Signature
Max Barrett
Lab Director, PuriLab Analytical
Analysis date: November 20, 2026
Verification Code
RT-9QIG-M45F
Verify at purilab.org/verify/RT-9QIG-M45F
Scan to Verify
RT-9QIG-M45F
Results apply solely to the sample as received and are not representative of any larger lot, batch, or production run. Findings are limited to the analytes stated above. PuriLab Analytical is an independent testing laboratory, is not CLIA certified or ISO 17025 accredited, does not sell or distribute any substance, and makes no representation as to the safety, legality, or fitness of any material for any use.
PuriLab Analytical|admin@purilab.org
Page 1 of 1